Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Additive Implants is a private U.S. medical device company focused on 3D-printed spinal interbody fusion implants and related instrumentation. The company designs and manufactures patented cervical and lumbar interbody fusion devices intended for spinal fusion procedures, particularly for degenerative disc disease and related spinal pathologies. Its marketed product family includes the SureMAX, SureMAX-X, and SureMAX-SA cervical spacer systems, which emphasize porous titanium structures, broad sizing options, and instrumentation designed to improve surgical flexibility and bone-implant interface stability. Additive Implants appears to operate as a commercial-stage spine hardware company rather than a therapeutics developer, with emphasis on implant geometry, fixation, and workflow efficiency for surgeons.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Additive Implants.